Home > Financial Ratios > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Core EBITDA Margin

    Back to All Ratios
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results

BALAXI PHARMACEUTICALS Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Margin(%) 3.5511.0118.4617.0718.19

What is the latest Core EBITDA Margin ratio of BALAXI PHARMACEUTICALS ?

The latest Core EBITDA Margin ratio of BALAXI PHARMACEUTICALS is 3.55 based on Mar2026 Consolidated results.
Year Core EBITDA Margin
Mar20263.55
Mar202511.01
Mar202418.46
Mar202317.07
Mar202218.19

How is Core EBITDA Margin of BALAXI PHARMACEUTICALS Trending?

Years Core EBITDA Margin % Change
Mar2026 3.55
-67.76
Mar2025 11.01
-40.36
Mar2024 18.46
8.14
Mar2023 17.07
-6.16
Mar2022 18.19 -

Other Financial Ratios of BALAXI PHARMACEUTICALS


Compare Core EBITDA Margin ratio of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹129.2 Cr 1.3% 5% -48% Stock Analytics
ADANI ENTERPRISES ₹404,763.0 Cr 2% -0% 29.8% Stock Analytics
AEGIS LOGISTICS ₹52,184.9 Cr 12.3% 11.6% 87.5% Stock Analytics
PREMIER ENERGIES ₹41,404.9 Cr -3.7% -12.1% -14.1% Stock Analytics
ADITYA INFOTECH ₹41,259.1 Cr -4.7% 0.4% 132% Stock Analytics
REDINGTON ₹30,626.0 Cr 3.6% 12.6% 65.5% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

1.3%

5%

-48%

SENSEX

0.1%

-2.7%

-8.6%


You may also like the below Video Courses